Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

papaverine/peavalu

Link salvestatakse lõikelauale
Leht 1 alates 18 tulemused

Papaverine in the prophylaxis of migraine and other vascular headache in children.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A daily dose of papaverine (5--10 mg per kg body weight) was administered on a double-blind basis for two months to 42 successive child patients suffering from migraine or other vascular headache attacks not less than twice a month. Thirty-seven patients received the drug for the whole period of two
This study was done to evaluate the effectiveness of transdermal nitroglycerin in the treatment of erectile dysfunction in males with spinal cord lesions as compared to the treatment with intracavernous injection of papaverine. The study design used was an open, randomized, cross over trial of
Oral therapy has become first line treatment for patients with mild to moderate erectile dysfunction (ED). Studies have shown that sildenafil may not be effective in all patients, and has been associated with a variety of adverse effects and an adverse interaction with nitrates and inhibitors of

Drugs for preventing migraine headaches in children.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND It has been estimated that about ten per cent of children between six and 20 years of age suffer from migraine. It is estimated that children with migraine lose one and a half weeks more schooling per year than their peers. Prophylactic drugs can be prescribed when children suffer from

Unruptured aneurysm: vasospasm after surgery and endovascular treatment. A case report.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CONCLUSIONS Arterial cerebral vasospasm in different pathological conditions other than subarachnoid haemorrhage (SAH) caused by ruptured aneurysm is uncommon. The haemodynamicsclinical consequences of such conditions makes a quick diagnosis, vital to choose the best therapeutic strategy. A

Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The aim of this study was to assess the efficacy of pharmacological prophylactic treatments of migraine in children. Databases were searched from inception to June 2004 and references were checked. We selected controlled trials on the effects of pharmacological prophylactic treatments in children

Acute haemorrhagic stroke.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE To review the management and some of the recent advances in acute haemorrhagic stroke. METHODS Articles and published reviews on acute haemorrhagic stroke. RESULTS Hypertensive intracerebral haemorrhage or subarachnoid haemorrhage (SAH) from a ruptured intracranial saccular aneurysm are

Autoregulation in the middle meningeal artery.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In cats anesthetized with alpha-chloralose, autoregulation of blood flow (F) in the middle meningeal and common carotid arteries was assessed by bleeding and subsequently reinfusing the animals to achieve a 25% step reduction in mean arterial blood pressure (P), while maintaining the systolic blood

Non-invasive management of impotence with transcutaneous nitroglycerin.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Nitroglycerin plasters were applied to the penis in 10 impotent men and the erectile effect assessed. During laboratory testing all patients achieved an erectile response. Self-administration of nitroglycerin patches restored potency in 4 patients and was preferred to papaverine auto-injection by 3.

[Long-term results of the treatment with intracavernous injection of vasoactive drugs].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE To evaluate the long-term results of treatment of erectile dysfunction with intracavernous self-injection of vasoactive drugs. METHODS The study comprised 144 patients treated with intracavernous self-injection. The most common etiologies were arterial (27%), corporal-veno-occlusive

Limb-threatening lower extremity ischemia successfully treated with intra-arterial infusion--case reports.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The authors present two patients with acute arterial vasospasm of the lower extremities causing marked ischemia. One patient had a history of Raynaud's disease, the second had been taking Cafergot for migraine headaches. Both patients's were given a test dose of intra-arterial tolazoline (50 mg).
BACKGROUND Cerebral vasospasm from pathology other than subarachnoid hemorrhage is uncommon. A case of severe vasospasm after resection of a suprasellar pilocytic astrocytoma is reported. METHODS A 45-year-old male presented with headache, left facial numbness, bilateral visual loss, and ataxia.

Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Erectile dysfunction (ED) has frequently been associated with Peyronie's Disease (PD) and may further compromise coitus. This is a retrospective analysis of ED in patients with PD since the release of sildenafil citrate (SC) focusing specifically on our patients' responses to SC. One-hundred seventy
OBJECTIVE To investigate the effect of chronic use of sildenafil and intracavernous injection (ICI) with trimix in men not responding to on-demand monotherapy with sildenafil or ICI with prostaglandin-E1 (PGE1). METHODS The study included 40 patients with erectile dysfunction (ED), with a mean (SD)

Verapamil in migraine prophylaxis--a five-year review.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine. This paper reviews the clinical pharmacology as it applied to headache and the current research on the clinical use of verapamil in migraine prophylaxis. Included are
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge